Table 2.

Characteristics at study period associated with the notification of the disclosure of their own HIV status in adolescents in Abidjan, Côte d'Ivoire

	Notification of disclosure in adolescents		Univariate model		Adjusted model
	Yes, N=63 n (%)	No, N=130 n (%)	OR [CI 95%]	p	aOR [IC 95%]	p
Centre
CEPREF	31 (48.4)	31 (48.4)	2.84 [1.51–5.36]	0.001	3.52 [1.15–10.85]	0.028
CHU Yopougon	32 (24.8)	32 (24.8)	1		1
Gender
Female	25 (30.9)	25 (30.9)	0.87 [0.47–1.60]	0.654	1.36 [0.53–3.48]	0.523
Male	38 (33.9)	38 (33.9)	1		1
Age group (years)
[13–15]	21 (18.6)	21 (18.6)	1	<0.0001	1	<0.0001
[16–18]	17 (33.3)	17 (33.3)	2.19 [1.03–4.6]		4.21 [1.54–11.49]
>18	25 (86.2)	25 (86.2)	27.38 [8.61–87.08]		22.08 [5.22–93.49]
History of participation in a research project
Yes	44 (37.9)	44 (37.9)	2.05 [1.06–3.96]	0.031	1.93 [0.61–6.08]	0.259
No	17 (23.0)	17 (23.0)	1		1
On ART
Yes	61 (34.5)	61 (34.5)	3.42 [0.75–15.63]	0.113	1.15 [0.09–15.21]	0.914
No	2 (13.3)	2 (13.3)	1		1
On cotrimoxazole prophylaxis
Yes	40 (39.6)	40 (39.6)	2.34 [1.15–4.78]	0.018	2.04 [0.77–5.41]	0.152
No	14 (21.9)	14 (21.9)	1		1
History of ART regimen change
Yes	46 (42.2)	46 (42.2)	4.13 [1.60–10.67]	0.003	3.83 [0.92–15.92]	0.065
No	6 (15.0)	6 (15.0)	1		1
Orphan of both parents
Yes	14 (29.2)	34 (70.8)	0.87 [0.61–1.24]	0.438	0.28 [0.09–0.88]	0.290
No	47 (35.3)	86 (64.7)	1		1

ART=antiretroviral therapy; OR=odds ratio; CI=confidence interval.

Univariate and adjusted logistic regression. PRADO-CI study, N=193.